NUTRACEUTICALS IN 2017: Nutraceuticals in endocrine disorders

    loading  Checking for direct PDF access through Ovid

Abstract

Nutraceuticals are gaining legitimacy and their potential clinical role is expanding. Data from 2017 provides evidence for their possible use in type 2 diabetes mellitus, the metabolic syndrome, obesity, dyslipidaemia and osteoporosis. Ongoing high-quality research in this area might justify future selective implementation of nutraceuticals into general health practice.

Related Topics

    loading  Loading Related Articles